Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alka Tecnologia em Diagnósticos is a leading Brazilian company specialized in the distribution and development of advanced in vitro diagnostic (IVD) solutions. Founded in 1996, the company provides a wide array of products including molecular biology kits, clinical chemistry reagents, and point-of-care testing devices to hospitals and laboratories across Brazil. Alka acts as a strategic partner for major international diagnostic brands, facilitating their market entry and technical support within the Latin American region. In 2021, the company was acquired by Grupo Elfa, a significant healthcare logistics and distribution platform in Brazil, to bolster its specialized diagnostics division. The company continues to operate as a high-tech hub for diagnostic innovation and commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alka Tecnologia em Diagnósticos.